Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts
- PMID: 9927278
- DOI: 10.1210/endo.140.2.6493
Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts
Abstract
Bone morphogenetic proteins (BMPs) are secreted by skeletal cells, induce the differentiation of mesenchymal cells into cells of the osteoblastic lineage, and increase their differentiated function. BMPs also decrease collagenase-3 expression by the osteoblast. We tested the autocrine role of BMPs on collagenase-3 expression in osteoblast-enriched cells from fetal rat calvariae (Ob cells) by examining the effects of noggin, a specific inhibitor of BMP binding and function. Although collagenase-3 transcript expression declined in untreated Ob cells in culture over a 24-h period, BMP-2, -4, and -6 decreased collagenase-3 messenger RNA levels in cells treated for 2-24 h. The addition of noggin prevented the decrease of collagenase-3 transcripts in control cultures, opposed the inhibitory actions of BMP-2, and increased the levels of the protease in the culture medium. Noggin did not alter the decay of collagenase-3 messenger RNA in transcriptionally arrested cells, and it increased the levels of collagenase-3 heterogeneous nuclear RNA in Ob cells. In conclusion, noggin enhances the synthesis of collagenase-3 in osteoblasts, supporting the notion that BMPs act as autocrine suppressors of collagenase-3 in skeletal cells, an effect that may contribute to the maintenance of the bone matrix.
Similar articles
-
Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures.Endocrinology. 1997 Mar;138(3):1035-40. doi: 10.1210/endo.138.3.4978. Endocrinology. 1997. PMID: 9048606
-
Bone morphogenetic protein-4 regulates its own expression in cultured osteoblasts.J Cell Physiol. 2000 Feb;182(2):239-46. doi: 10.1002/(SICI)1097-4652(200002)182:2<239::AID-JCP13>3.0.CO;2-W. J Cell Physiol. 2000. PMID: 10623888
-
Transforming growth factor beta1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures.J Cell Physiol. 1997 Feb;170(2):145-52. doi: 10.1002/(SICI)1097-4652(199702)170:2<145::AID-JCP6>3.0.CO;2-O. J Cell Physiol. 1997. PMID: 9009143
-
Bone morphogenetic proteins, their antagonists, and the skeleton.Endocr Rev. 2003 Apr;24(2):218-35. doi: 10.1210/er.2002-0023. Endocr Rev. 2003. PMID: 12700180 Review.
-
The regulation and regulatory role of collagenase in bone.Crit Rev Eukaryot Gene Expr. 1996;6(1):15-27. doi: 10.1615/critreveukargeneexpr.v6.i1.20. Crit Rev Eukaryot Gene Expr. 1996. PMID: 8882305 Review.
Cited by
-
Osteoporosis--a risk factor for cardiovascular disease?Nat Rev Rheumatol. 2012 Oct;8(10):587-98. doi: 10.1038/nrrheum.2012.120. Epub 2012 Aug 14. Nat Rev Rheumatol. 2012. PMID: 22890244 Review.
-
Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes.J Biol Chem. 2003 Jul 11;278(28):25386-94. doi: 10.1074/jbc.M302048200. Epub 2003 May 6. J Biol Chem. 2003. PMID: 12734180 Free PMC article.
-
Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types.Elife. 2022 Aug 9;11:e76228. doi: 10.7554/eLife.76228. Elife. 2022. PMID: 35942681 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
